Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03855241 · ClinicalTrials.gov registry record · NA

Safely Disposing of Surplus Prescription Opioids

A NA study of Opioid Use, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
499
Enrollment target
1
Study location

NCT03855241 is a NA study of Opioid Use that has completed, run by Johns Hopkins University. The registered enrollment target is 499 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03855241, a NA study of Opioid Use, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
499 participants
Enrollment target
1
Study location

Study Summary

This study evaluates two interventions intended to increase the safe disposal of leftover prescription opioids, compared to no intervention. Participants will receive an informational sheet describing how to safely dispose of leftover prescription opioids, an informational sheet with a drug disposal kit, or no intervention. Participants will be randomized by day for pragmatic reasons.

Conditions Studied

Interventions

  • BEHAVIORAL Informational Sheet
  • BEHAVIORAL DisposeRx Drug Disposal kit

Study Locations (1)

Maryland

  • Johns Hopkins Hospital/Johns Hopkins Outpatient Center - Baltimore

Trial Details

FieldValue
Enrollment Target 499 participants
Start Date 2019-06-05
Est. Completion 2019-08-14
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03855241

The ClinicalTrials.gov registry entry for NCT03855241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Informational Sheet is the first listed.

NCT03855241 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03855241 about?

NCT03855241 is a clinical study titled "Safely Disposing of Surplus Prescription Opioids". This study evaluates two interventions intended to increase the safe disposal of leftover prescription opioids, compared to no intervention. Participants will receive an informational sheet describing how to safely dispose of leftover prescription opioids, an informational sheet with a drug disposal...

What is the current status of trial NCT03855241?

This trial is currently completed. It is a NA study. The enrollment target is 499 participants. The study started on 2019-06-05. Estimated completion is 2019-08-14.

What conditions does trial NCT03855241 study?

This clinical trial studies the following conditions: Opioid Use.

What interventions are being tested in trial NCT03855241?

The interventions under investigation include: Informational Sheet (BEHAVIORAL), DisposeRx Drug Disposal kit (BEHAVIORAL).

Who is sponsoring clinical trial NCT03855241?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03855241 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.